• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房颤动、静脉血栓栓塞与肺动脉高压风险:一项瑞典全国性注册研究

Atrial Fibrillation, Venous Thromboembolism, and Risk of Pulmonary Hypertension: A Swedish Nationwide Register Study.

作者信息

Hjalmarsson Clara, Lindgren Martin, Bergh Niklas, Hornestam Björn, Smith J G, Adiels Martin, Rosengren Annika

机构信息

Department of Cardiology Sahlgrenska University Hospital Gothenburg Sweden.

Department of Molecular and Clinical Medicine, Institute of Medicine at Sahlgrenska Academy University of Gothenburg Gothenburg Sweden.

出版信息

J Am Heart Assoc. 2025 May 6;14(9):e037418. doi: 10.1161/JAHA.124.037418. Epub 2025 May 2.

DOI:10.1161/JAHA.124.037418
PMID:40314359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12184232/
Abstract

BACKGROUND

Atrial fibrillation (AF) is suggested to be associated with venous thromboembolism (VTE) and might thereby play a role in the development of chronic thromboembolic pulmonary hypertension (PH). By elevating left-sided filling pressure and promoting atrial myopathy, AF may also play a role in the development of postcapillary PH. We aimed to investigate the association between AF, with or without incident VTE, and the occurrence of PH.

METHODS

A total of 521 988 patients diagnosed with AF between 1987 and 2013, without a previous diagnosis of VTE or PH, were identified from the Swedish National Patient Register and matched for age, sex, and county with 1 017 277 population controls without AF, VTE, or PH.

RESULTS

The mean age of the patients with AF was 71.1 (SD ±10.1) years and 42.8% were women. During a median follow-up period of 11 (interquartile range 5.1-17) years, 4454 (0.9%) patients with AF, and 1855 (0.2%) controls were diagnosed with PH, hazard ratio 4.7 (4.4-5.0). The AF group had a significantly higher comorbidity burden at baseline, with a mean CHADS-VASc of 2.9 compared with 2.1 in controls. In the absence of intercurrent VTE, the hazard ratio of PH was 4.2 (3.9-4.5) among patients with AF compared with controls. Intercurrent VTE increased the hazard ratio of PH a further 1.9-fold (1.7-2.1) and 3.5 (3.1-4.0), among patients with AF and controls, respectively. The hazard ratio for PH in patients with AF with incident VTE was 8.1 (7.3-9.1).

CONCLUSIONS

AF was associated with a markedly increased risk of developing incident PH, and this risk was further increased by incident VTE.

摘要

背景

房颤(AF)被认为与静脉血栓栓塞(VTE)有关,因此可能在慢性血栓栓塞性肺动脉高压(PH)的发生中起作用。通过升高左心房充盈压和促进心房肌病,房颤也可能在毛细血管后肺动脉高压的发生中起作用。我们旨在研究伴有或不伴有新发VTE的房颤与肺动脉高压发生之间的关联。

方法

从瑞典国家患者登记处识别出1987年至2013年间共521988例诊断为房颤且既往未诊断为VTE或PH的患者,并将其与1017277例无房颤、VTE或PH的人群对照按年龄、性别和所在县进行匹配。

结果

房颤患者的平均年龄为71.1(标准差±10.1)岁,42.8%为女性。在中位随访期11(四分位间距5.1 - 17)年期间,4454例(0.9%)房颤患者和1855例(0.2%)对照被诊断为肺动脉高压,风险比为4.7(4.4 - 5.0)。房颤组在基线时合并症负担显著更高,平均CHADS - VASc评分为2.9,而对照组为2.1。在无并发VTE的情况下,房颤患者发生肺动脉高压的风险比为4.2(3.9 - 4.5),与对照组相比。并发VTE分别使房颤患者和对照组发生肺动脉高压的风险比进一步增加1.9倍(1.7 - 2.1)和3.5倍(3.1 - 4.0)。伴有新发VTE的房颤患者发生肺动脉高压的风险比为8.1(7.3 - 9.1)。

结论

房颤与新发肺动脉高压的风险显著增加相关,且这种风险因新发VTE而进一步增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b147/12184232/1883f2e11df9/JAH3-14-e037418-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b147/12184232/fe9a28f59687/JAH3-14-e037418-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b147/12184232/1883f2e11df9/JAH3-14-e037418-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b147/12184232/fe9a28f59687/JAH3-14-e037418-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b147/12184232/1883f2e11df9/JAH3-14-e037418-g002.jpg

相似文献

1
Atrial Fibrillation, Venous Thromboembolism, and Risk of Pulmonary Hypertension: A Swedish Nationwide Register Study.心房颤动、静脉血栓栓塞与肺动脉高压风险:一项瑞典全国性注册研究
J Am Heart Assoc. 2025 May 6;14(9):e037418. doi: 10.1161/JAHA.124.037418. Epub 2025 May 2.
2
Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis.口服抗凝剂用于静脉血栓栓塞性疾病的一级预防、治疗和二级预防,以及用于心房颤动的卒中预防:系统评价、网状荟萃分析和成本效益分析。
Health Technol Assess. 2017 Mar;21(9):1-386. doi: 10.3310/hta21090.
3
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
4
Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.对无诱因静脉血栓栓塞症(VTE)患者进行癌症检测对癌症及VTE相关死亡率和发病率的影响。
Cochrane Database Syst Rev. 2017 Aug 23;8(8):CD010837. doi: 10.1002/14651858.CD010837.pub3.
5
Long-term hormone therapy for perimenopausal and postmenopausal women.围绝经期和绝经后女性的长期激素治疗
Cochrane Database Syst Rev. 2017 Jan 17;1(1):CD004143. doi: 10.1002/14651858.CD004143.pub5.
6
Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.对有静脉血栓栓塞风险的住院患者实施血栓预防的干预措施。
Cochrane Database Syst Rev. 2018 Apr 24;4(4):CD008201. doi: 10.1002/14651858.CD008201.pub3.
7
Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.不明原因静脉血栓栓塞症(VTE)患者中,检测癌症对癌症或静脉血栓栓塞症(VTE)相关死亡率和发病率的影响。
Cochrane Database Syst Rev. 2021 Oct 1;10(10):CD010837. doi: 10.1002/14651858.CD010837.pub5.
8
Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.非维生素K拮抗剂口服抗凝剂用于心房颤动和静脉血栓栓塞的有效性和安全性:一项系统评价和荟萃分析
Clin Ther. 2017 Jul;39(7):1456-1478.e36. doi: 10.1016/j.clinthera.2017.05.358. Epub 2017 Jun 28.
9
Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.心房颤动和典型心房扑动的根治性导管消融术:系统评价与经济评估
Health Technol Assess. 2008 Nov;12(34):iii-iv, xi-xiii, 1-198. doi: 10.3310/hta12340.
10
Smart Technology Facilitated Patient-Centered Venous Thromboembolism Management (the SmaVTE Study): Protocol for a Randomized Controlled Trial.智能技术辅助的以患者为中心的静脉血栓栓塞管理(SmaVTE研究):一项随机对照试验的方案
JMIR Res Protoc. 2025 Jun 5;14:e67254. doi: 10.2196/67254.

本文引用的文献

1
Pulmonary hypertension: An unexplored risk factor for stroke in patients with atrial fibrillation.肺动脉高压:房颤患者卒中的一个未被探索的危险因素。
J Stroke Cerebrovasc Dis. 2023 Sep;32(9):107247. doi: 10.1016/j.jstrokecerebrovasdis.2023.107247. Epub 2023 Jul 29.
2
Incidence and Risk Factors of Pulmonary Hypertension After Venous Thromboembolism: An Analysis of a Large Health Care Database.静脉血栓栓塞后肺动脉高压的发生率和危险因素:大型医疗保健数据库分析。
J Am Heart Assoc. 2022 Jul 19;11(14):e024358. doi: 10.1161/JAHA.121.024358. Epub 2022 Jul 15.
3
A Novel Factor in Determining the Risk of Ischemic Cerebrovascular Events in Patients with Atrial Fibrillation: Pulmonary Hypertension.
心房颤动患者缺血性脑血管事件风险的一个新决定因素:肺动脉高压
J Stroke Cerebrovasc Dis. 2022 Apr;31(4):106387. doi: 10.1016/j.jstrokecerebrovasdis.2022.106387. Epub 2022 Feb 16.
4
Atrial fibrillation and risk of venous thromboembolism: a Swedish Nationwide Registry Study.心房颤动与静脉血栓栓塞风险:一项瑞典全国性注册研究
Europace. 2021 Dec 7;23(12):1913-1921. doi: 10.1093/europace/euab180.
5
Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation.射血分数保留的心力衰竭伴心房颤动患者的心房功能障碍。
J Am Coll Cardiol. 2020 Sep 1;76(9):1051-1064. doi: 10.1016/j.jacc.2020.07.009.
6
A diagnosis of atrial fibrillation is not a predictor for pulmonary embolism.心房颤动的诊断不是肺栓塞的预测因素。
Thromb Res. 2020 Nov;195:238-242. doi: 10.1016/j.thromres.2020.08.019. Epub 2020 Aug 10.
7
Atrial fibrillation and venous thromboembolism: evidence of bidirectionality in the Atherosclerosis Risk in Communities Study.心房颤动与静脉血栓栓塞症:社区动脉粥样硬化风险研究中的双向证据。
J Thromb Haemost. 2018 Apr;16(4):670-679. doi: 10.1111/jth.13974. Epub 2018 Mar 13.
8
Risk of arterial and venous thromboembolism in patients with atrial fibrillation or flutter: A nationwide population-based cohort study.心房颤动或心房扑动患者发生动脉和静脉血栓栓塞的风险:一项基于全国人群的队列研究。
Int J Cardiol. 2017 Aug 15;241:182-187. doi: 10.1016/j.ijcard.2017.04.081. Epub 2017 Apr 26.
9
Atrial fibrillation and future risk of venous thromboembolism:the Tromsø study.心房颤动与静脉血栓栓塞的未来风险:特罗姆瑟研究。
J Thromb Haemost. 2015 Jan;13(1):10-6. doi: 10.1111/jth.12762. Epub 2014 Nov 22.
10
Atrial fibrillation associated with increased risk of venous thromboembolism. A population-based cohort study.心房颤动与静脉血栓栓塞风险增加相关。一项基于人群的队列研究。
Thromb Haemost. 2015 Jan;113(1):185-92. doi: 10.1160/TH14-05-0405. Epub 2014 Oct 16.